scholarly journals Successful Management of Enzyme Replacement Therapy in Related Fabry Disease Patients with Severe Adverse Events by Switching from Agalsidase Beta (Fabrazyme®) to Agalsidase Alfa (Replagal®)

2014 ◽  
Author(s):  
Kazuya Tsuboi ◽  
Hiroshi Yamamoto ◽  
Fuji Somura ◽  
Hiromi Goto
Keyword(s):  
Adverse Events ◽  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Agalsidase Beta ◽  
Successful Management ◽  
Enzyme Replacement ◽  
Agalsidase Alfa ◽  
Severe Adverse Events

Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta

2008 ◽  
Vol 95 (1-2) ◽  
pp. 114-115 ◽  
Author(s):  
Atul Mehta ◽  
Michael Beck ◽  
Christoph Kampmann ◽  
Andrea Frustaci ◽  
Dominique P. Germain ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Agalsidase Beta ◽  
Enzyme Replacement ◽  
Agalsidase Alfa

scholarly journals Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa

2014 ◽  
Vol 77 (4) ◽  
pp. 190-197 ◽  
Author(s):  
Hsiang-Yu Lin ◽  
Yu-Hsiu Huang ◽  
Hsuan-Chieh Liao ◽  
Hao-Chuan Liu ◽  
Ting-Rong Hsu ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Agalsidase Beta ◽  
Enzyme Replacement ◽  
Clinical Observations ◽  
Agalsidase Alfa

Prospective Results of Switching Enzyme Replacement Therapy from Agalsidase beta to Agalsidase alfa in the Canadian Fabry Disease Initiative Study

2012 ◽  
Vol 105 (2) ◽  
pp. S64-S65
Author(s):  
Michael West ◽  
Daniel Bichet ◽  
Robin Casey ◽  
Joe Clarke ◽  
Sandra Sirrs ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Agalsidase Beta ◽  
Enzyme Replacement ◽  
Agalsidase Alfa

scholarly journals Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease

2015 ◽  
pp. 95-106 ◽  
Author(s):  
Ozlem Goker-Alpan ◽  
Michael J. Gambello ◽  
Gustavo H. B. Maegawa ◽  
Khan J. Nedd ◽  
Daniel J. Gruskin ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Agalsidase Beta ◽  
Enzyme Replacement ◽  
Agalsidase Alfa

Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease

2009 ◽  
Vol 144 (1) ◽  
pp. 92-93 ◽  
Author(s):  
G. Kalkum ◽  
D. Macchiella ◽  
J. Reinke ◽  
H. Kölbl ◽  
M. Beck
Keyword(s):  
Enzyme Replacement Therapy ◽  
Pregnant Women ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Enzyme Replacement ◽  
Agalsidase Alfa

Burden of Fabry disease in young patients (≤30 years of age) who were initiated on enzyme replacement therapy with agalsidase beta: a Fabry Registry analysis

2017 ◽  
Vol 120 (1-2) ◽  
pp. S65-S66
Author(s):  
Robert J. Hopkin ◽  
Eva Brand ◽  
Ulla F. Rasmussen ◽  
Dominique P. Germain ◽  
Nathalie Guffon ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Young Patients ◽  
Agalsidase Beta ◽  
Enzyme Replacement ◽  
Registry Analysis

scholarly journals An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy

2016 ◽  
pp. 1771 ◽  
Author(s):  
Ozlem Goker-Alpan ◽  
Nicola Longo ◽  
Marie McDonald ◽  
Suma Shankar ◽  
Raphael Schiffmann ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Enzyme Replacement Therapy ◽  
Fabry Disease ◽  
Replacement Therapy ◽  
Open Label ◽  
Enzyme Replacement ◽  
Agalsidase Alfa
Sign in / Sign up

Export Citation Format

Share Document